Insigneo member Annamaria Carusi, was one of the experts included in the NC3Rs Adverse Outcome Pathways (AOP) newsletter, speaking on…Read More
The Insigneo Institute for in silico Medicine seeks to achieve scientific ambition behind the Virtual Physiological Human (VPH), producing a transformational impact on healthcare.
Insigneo brings together highly respected researchers and clinicians from across the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust. Members collaborate across disciplines and with international partners in industry, academia and healthcare. This enables Insigneo to define and address, with the wider VPH community, clinical and technological challenges inherent in in silico medicine.